Adage Capital Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.4M | Sell |
65,807
-145,300
| -69% | -$31.8M | 0.02% | 528 |
|
2025
Q1 | $47.3M | Sell |
211,107
-31,600
| -13% | -$7.07M | 0.09% | 237 |
|
2024
Q4 | $79.5M | Buy |
242,707
+64,300
| +36% | +$21.1M | 0.14% | 142 |
|
2024
Q3 | $53.6M | Buy |
178,407
+8,500
| +5% | +$2.55M | 0.09% | 221 |
|
2024
Q2 | $56M | Sell |
169,907
-27,700
| -14% | -$9.12M | 0.1% | 200 |
|
2024
Q1 | $78.2M | Buy |
197,607
+125,700
| +175% | +$49.7M | 0.15% | 142 |
|
2023
Q4 | $25.3M | Sell |
71,907
-1,500
| -2% | -$528K | 0.05% | 356 |
|
2023
Q3 | $27.5M | Sell |
73,407
-600
| -0.8% | -$225K | 0.06% | 311 |
|
2023
Q2 | $28.3M | Sell |
74,007
-75,100
| -50% | -$28.7M | 0.06% | 319 |
|
2023
Q1 | $51.7M | Buy |
149,107
+73,800
| +98% | +$25.6M | 0.12% | 207 |
|
2022
Q4 | $17.7M | Sell |
75,307
-100
| -0.1% | -$23.5K | 0.04% | 475 |
|
2022
Q3 | $18.6M | Sell |
75,407
-1,700
| -2% | -$418K | 0.05% | 428 |
|
2022
Q2 | $23.3M | Sell |
77,107
-200
| -0.3% | -$60.5K | 0.05% | 381 |
|
2022
Q1 | $31.8M | Sell |
77,307
-1,600
| -2% | -$657K | 0.06% | 325 |
|
2021
Q4 | $37M | Sell |
78,907
-500
| -0.6% | -$235K | 0.07% | 300 |
|
2021
Q3 | $33.7M | Sell |
79,407
-1,100
| -1% | -$467K | 0.07% | 299 |
|
2021
Q2 | $28.9M | Buy |
80,507
+24,700
| +44% | +$8.87M | 0.06% | 348 |
|
2021
Q1 | $15.7M | Sell |
55,807
-1,500
| -3% | -$423K | 0.03% | 536 |
|
2020
Q4 | $16.2M | Sell |
57,307
-25,250
| -31% | -$7.15M | 0.04% | 471 |
|
2020
Q3 | $22.7M | Sell |
82,557
-2,700
| -3% | -$742K | 0.06% | 343 |
|
2020
Q2 | $19.4M | Buy |
+85,257
| New | +$19.4M | 0.05% | 389 |
|
2019
Q1 | – | Sell |
-130,000
| Closed | -$12.7M | – | 743 |
|
2018
Q4 | $12.7M | Sell |
130,000
-20,000
| -13% | -$1.96M | 0.04% | 450 |
|
2018
Q3 | $18.5M | Buy |
+150,000
| New | +$18.5M | 0.04% | 417 |
|